Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Winston J. Churchill currently holds 9,893.06 shares of Recro Pharma, Inc. (REPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Winston J. Churchill has been a net seller of REPH stock. They have purchased $4.5M and sold $9.8M worth of shares.
Winston J. Churchill's most recent insider trade was on Mar 31, 2026, when they sold 18.16 shares at $0.00 per share.
Winston J. Churchill serves as Executive at Recro Pharma, Inc. (REPH). They have executed 236 insider transactions totaling $14.3M over their tenure at the company.
Winston J. Churchill holds the position of Executive at Recro Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Winston J. Churchill has shown a selling trading pattern, with $4.5M in total purchases and $9.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Winston J. Churchill was on Aug 27, 2024, when they sold $659.4K worth of AMKR shares. This transaction involved 20,000 shares at $32.97 per share.
Winston J. Churchill currently owns 9,893.06 shares of Recro Pharma, Inc. (REPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Winston J. Churchill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Winston J. Churchill has 236 Form 4 filings on record as an insider at Recro Pharma, Inc..
Set alerts for Winston J. Churchill and 40,000+ other insiders.